This company listing is no longer active
METabolic EXplorer Past Earnings Performance
Past criteria checks 0/6
METabolic EXplorer's earnings have been declining at an average annual rate of -239.2%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 36.4% per year.
Key information
-239.2%
Earnings growth rate
-166.5%
EPS growth rate
| Chemicals Industry Growth | 10.4% |
| Revenue growth rate | -36.4% |
| Return on equity | -51.9% |
| Net Margin | -29.3% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Feb 10
Why Investors Shouldn't Be Surprised By METabolic EXplorer S.A.'s (EPA:METEX) 27% Share Price Plunge
Dec 18Health Check: How Prudently Does METabolic EXplorer (EPA:METEX) Use Debt?
Oct 01News Flash: One METabolic EXplorer S.A. (EPA:METEX) Analyst Has Been Trimming Their Revenue Forecasts
Jul 30Downgrade: The Latest Revenue And EPS Forecasts For METabolic EXplorer S.A. (EPA:METEX)
Jul 10Does METabolic EXplorer (EPA:METEX) Have A Healthy Balance Sheet?
Jun 14Is METabolic EXplorer S.A. (EPA:METEX) Potentially Undervalued?
May 10What Is METabolic EXplorer S.A.'s (EPA:METEX) Share Price Doing?
Jan 25Statutory Earnings May Not Be The Best Way To Understand METabolic EXplorer's (EPA:METEX) True Position
Oct 06METabolic EXplorer (EPA:METEX) Has Debt But No Earnings; Should You Worry?
May 12The METabolic EXplorer (EPA:METEX) Share Price Has Soared 428%, Delighting Many Shareholders
Mar 18Investors Who Bought METabolic EXplorer (EPA:METEX) Shares A Year Ago Are Now Up 74%
Dec 03
Revenue & Expenses Breakdown
How METabolic EXplorer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 168 | -49 | 30 | 9 |
| 31 Mar 23 | 198 | -50 | 32 | 9 |
| 31 Dec 22 | 228 | -51 | 33 | 10 |
| 30 Sep 22 | 246 | -33 | 33 | 10 |
| 30 Jun 22 | 264 | -15 | 33 | 10 |
| 31 Mar 22 | 218 | 34 | 29 | 9 |
| 31 Dec 21 | 172 | 83 | 24 | 8 |
| 30 Sep 21 | 105 | 79 | 17 | 7 |
| 30 Jun 21 | 38 | 75 | 9 | 6 |
| 31 Mar 21 | 20 | 33 | 7 | 6 |
| 31 Dec 20 | 2 | -9 | 4 | 6 |
| 30 Sep 20 | 2 | -9 | 5 | 6 |
| 30 Jun 20 | 2 | -8 | 5 | 6 |
| 31 Mar 20 | 2 | -8 | 5 | 6 |
| 31 Dec 19 | 2 | -8 | 5 | 5 |
| 30 Sep 19 | 3 | -9 | 5 | 5 |
| 30 Jun 19 | 3 | -9 | 5 | 5 |
| 31 Mar 19 | 4 | -8 | 5 | 5 |
| 31 Dec 18 | 6 | -6 | 5 | 5 |
| 30 Sep 18 | 6 | -9 | 5 | 6 |
| 30 Jun 18 | 7 | -11 | 5 | 6 |
| 31 Mar 18 | 7 | -11 | 4 | 6 |
| 31 Dec 17 | 7 | -11 | 4 | 6 |
| 30 Sep 17 | 6 | -1 | 4 | 6 |
| 30 Jun 17 | 6 | 8 | 4 | 6 |
| 31 Mar 17 | 5 | 7 | 4 | 7 |
| 31 Dec 16 | 4 | 7 | 4 | 7 |
| 30 Sep 16 | 4 | 0 | 4 | 7 |
| 30 Jun 16 | 4 | -7 | 4 | 7 |
| 31 Mar 16 | 3 | -7 | 4 | 7 |
| 31 Dec 15 | 3 | -7 | 4 | 6 |
| 30 Sep 15 | 4 | -7 | 4 | 6 |
| 30 Jun 15 | 4 | -6 | 4 | 5 |
| 31 Mar 15 | 5 | -5 | 4 | 5 |
| 31 Dec 14 | 6 | -4 | 4 | 5 |
| 30 Sep 14 | 4 | -3 | 4 | 4 |
| 30 Jun 14 | 3 | -2 | 4 | 3 |
| 31 Mar 14 | 2 | -3 | 4 | 2 |
| 31 Dec 13 | 1 | -4 | 4 | 1 |
Quality Earnings: METEX is currently unprofitable.
Growing Profit Margin: METEX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if METEX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare METEX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: METEX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-31.3%).
Return on Equity
High ROE: METEX has a negative Return on Equity (-51.87%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/09 20:55 |
| End of Day Share Price | 2024/10/09 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
METabolic EXplorer S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles-Louis Planade | Arkeon Finance |
| Arsene Guekam | CIC Market Solutions (ESN) |
| Charles Bordes | Kepler Cheuvreux |